clinical trials semaglutide A trial from the University of Colorado Anschutz found oral semaglutide, the medication behind Ozempic and Wegovy, can reduce heavy drinking in adults with alcohol use disorder. Read more: https://www.forbes.com/sites/antoniopequenoiv/2026/07 Enrollment Excellence in Phase-3 Semaglutide

Tirzepatide injections help millions manage weight by activating dual GLP-1 and GIP receptors in the brain, but some patients experience localized itching at the injection site

GLP-1 medications like semaglutide and tirzepatide mimic the GLP-1 hormone, enhancing its effects to help regulate blood sugar and curb hunger, leading to lower calorie intake and weight loss

Patients with established cardiovascular disease including previous myocardial infarction, stroke, or peripheral arterial diseaseare particularly suitable candidates, given the proven cardiovascular benefits of both drug classes

Eat balanced meals at regular intervals to maintain stable blood sugar levels because low blood sugar levels can trigger headaches